Cellectis SA (CLLS)
1.26
+0.01
(+0.80%)
USD |
NASDAQ |
Oct 09, 16:00
1.25
-0.01
(-0.79%)
After-Hours: 20:00
Cellectis Cash from Operations (Quarterly) : -14.34M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -14.34M |
| March 31, 2026 | -15.56M |
| December 31, 2025 | -10.47M |
| September 30, 2025 | -1.627M |
| June 30, 2025 | -10.72M |
| March 31, 2025 | -17.31M |
| December 31, 2024 | -0.263M |
| September 30, 2024 | -6.072M |
| June 30, 2024 | 52.02M |
| March 31, 2024 | -23.54M |
| December 31, 2023 | 39.61M |
| September 30, 2023 | -17.17M |
| June 30, 2023 | -19.20M |
| March 31, 2023 | -28.40M |
| December 31, 2022 | -1.372M |
| September 30, 2022 | -26.09M |
| June 30, 2022 | -23.52M |
| March 31, 2022 | -36.61M |
| December 31, 2021 | -21.28M |
| September 30, 2021 | -30.59M |
| June 30, 2021 | -12.12M |
| Date | Value |
|---|---|
| March 31, 2021 | -40.93M |
| December 31, 2020 | -33.89M |
| September 30, 2020 | -25.61M |
| June 30, 2020 | -22.22M |
| March 31, 2020 | 1.458M |
| December 31, 2019 | -2.883M |
| September 30, 2019 | -22.65M |
| June 30, 2019 | -21.22M |
| March 31, 2019 | -22.40M |
| December 31, 2018 | -20.60M |
| September 30, 2018 | -15.01M |
| June 30, 2018 | -12.54M |
| March 31, 2018 | -19.98M |
| December 31, 2017 | -9.465M |
| September 30, 2017 | -15.54M |
| June 30, 2017 | -9.975M |
| March 31, 2017 | -17.35M |
| December 31, 2016 | 5.563M |
| September 30, 2016 | -5.792M |
| June 30, 2016 | -10.87M |
| March 31, 2016 | -21.60M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| DBV Technologies SA | -52.52M |
| Akari Therapeutics Plc | -3.112M |
| EDAP TMS SA | -3.687M |
| Bicycle Therapeutics Plc | -49.69M |
| argenx SE | -- |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 18.75M |
| Cash from Financing (Quarterly) | -3.157M |
| Free Cash Flow | -45.36M |
| Free Cash Flow Per Share (Quarterly) | -0.145 |
| Free Cash Flow to Equity (Quarterly) | -10.27M |
| Free Cash Flow to Firm (Quarterly) | -12.72M |
| Free Cash Flow Yield | -35.71% |